Unrestricted prescription of dabigatran: Is it safe in a resource-limited setting
Supradip Ghosh
Citation Information :
Ghosh S. Unrestricted prescription of dabigatran: Is it safe in a resource-limited setting. Indian J Crit Care Med 2013; 17 (5):325-326.
Schiele F, van Ryn J, Canada K, Newsome C, Sepulveda E, Park J, et al. A specific antidote for Dabigatran: Functional and structural characterization. Blood 2013;121:3554-62.
Dager WE, Gosselin RC, Roberts AJ. Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity. Crit Care Med 2013;41:e42-6.
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
Harper P, Young L, Merriman E. Bleeding risk with Dabigatran in the frail elderly. N Engl J Med 2012;366:864-6.
Uchino K, Hernandez AV. Dabigatran association with higher risk of acute coronary events. Arch Intern Med 2012;172:397-402.